项目 血细胞成分 | 治疗前组 | 治疗后组 | ||
N | ( ) | N | ( ) | |
WBC (109/L) | 15 | 12.84 ± 3.64a | 15 | 13.06 ± 4.49a |
LYM (%) | 15 | 40.62 ± 11.94a | 15 | 46.45 ± 14.42a |
MID (%) | 15 | 15.30 ± 3.21a | 15 | 12.46 ± 3.90b |
GRAN (%) | 15 | 42.04 ± 7.51a | 15 | 61.76 ± 76.75a |
LYM (109/L) | 15 | 5.59 ± 2.15a | 15 | 5.85 ± 2.59a |
MID (109/L) | 15 | 2.02 ± 0.74a | 15 | 1.56 ± 0.52a |
GRAN (109/L) | 15 | 5.23 ± 1.29a | 15 | 5.58 ± 3.78a |
RBC (1012/L) | 15 | 4.89 ± 0.83a | 15 | 5.47 ± 0.87a |
HGB (g/L) | 15 | 109.40 ± 22.73a | 15 | 109.27 ± 16.31a |
HCT (%) | 15 | 24.10 ± 4.41a | 15 | 28.33 ± 6.34b |
MCV (fL) | 15 | 49.23 ± 0.87a | 15 | 50.59 ± 2.11b |
MCH (pg) | 15 | 22.17 ± 2.86a | 15 | 20.04 ± 1.82b |
MCHC (g/L) | 15 | 461.20 ± 63.05a | 15 | 398.80 ± 46.99b |
RDW-SD (fL) | 15 | 18.83 ± 1.18a | 15 | 20.19 ± 2.08a |
RDW-CV (%) | 15 | 12.49 ± 0.68a | 15 | 13.08 ± 0.96a |